TrialJournal for immunotherapy of cancer2024

Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial.

Lucy X Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.